Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shehuang Piyan Gao is a Traditional Chinese Medicine (TCM)-Western hybrid topical ointment developed and manufactured by Chengdu Huasen Pharmaceutical Co., Ltd. It is primarily indicated for the treatment of chronic eczema and neurodermatitis. The formulation combines the potent anti-inflammatory and immunosuppressive properties of dexamethasone acetate, a synthetic glucocorticoid, with traditional ingredients such as artificial musk, sulfur, and borneol. Additionally, it contains menthol and methyl salicylate, which act as counter-irritants to provide rapid relief from itching and pain. This multi-component approach targets both the underlying inflammatory process and the symptomatic discomfort associated with chronic dermatological conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shehuang piyan gao.